Changes in outpatient lithium treatment in the Netherlands during 1996-2005

Journal of Affective Disorders

Volumn 111, Issue 1, 2008, Pages 94-99

  Wilting, I ^a,b   Souverein, P C ^a   Nolen, W A ^c   Egberts, A C G ^a,b   Heerdink, E R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atypical antipsychotics; Bipolar disorders; Incidence; Lithium; Prevalence

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADD ON THERAPY; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; HUMAN; NETHERLANDS; OUTPATIENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; HUMANS; LITHIUM COMPOUNDS; NETHERLANDS; PATIENT DROPOUTS; PRACTICE GUIDELINES AS TOPIC; VALPROIC ACID;

EID: 52149120900     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.01.019     Document Type: Article

References (18)

1. Anonymous. Bestuur Nederlandse Vereniging voor Psychiatrie. Richtlijnen Nederlandse Vereniging voor Psychiatrie richtlijn farmacotherapie bij bipolaire stoornissen (2001), Boom, Amsterdam
2. Blanco C., Laje G., Olfson M., Marcus S.C., and Pincus H.A. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 159 (2002) 1005-1010
3. Bottlender R., Rudolf D., Strauss A., and Moller H.J. Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression. Eur. Arch. Psychiatry Clin. Neurosci. 248 (1998) 296-300
4. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271 (1994) 918-924
5. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60 (2003) 392-400
6. Castells X., Vallano A., Rigau D., Perez J., Casas M., and Capella D. Trends in lithium prescription in Spain from 1985 to 2003. J. Affect. Disord. 91 (2006) 273-276
7. Davids E., Bunk C., Specka M., and Gastpar M. Psychotropic drug prescription in a psychiatric university hospital in Germany. Prog. Neuro-psychopharmacol. Biol. Psychiatry 30 (2006) 1109-1116
8. Dunner D.L. Safety and tolerability of emerging pharmacological treatments for bipolar disorder. Bipolar. Disord. 7 (2005) 307-325
9. Fenn H.H., Robinson D., Luby V., Dangel C., Buxton E., Beattie M., et al. Trends in pharmacotherapy of schizoaffective and bipolar affective disorders: a 5-year naturalistic study. Am. J. Psychiatry 153 (1996) 711-713
10. Gijsman H.J., Geddes J.R., Rendell J.M., Nolen W.A., and Goodwin G.M. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am. J. Psychiatry 161 (2004) 1537-1547
11. Greil W., Ludwig-Mayerhofer W., Erazo N., Schochlin C., Schmidt S., Engel R.R., et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study. J. Affect. Disord. 43 (1997) 151-161
12. Herings, R.M.C., 1993. Pharmo. A record linkage system for postmarketing surveillance of prescription drugs in the Netherlands [dissertation]. Utrecht: Utrecht University.
13. Nemeroff C.B., Evans D.L., Gyulai L., Sachs G.S., Bowden C.L., Gergel I.P., et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am. J. Psychiatry 158 (2001) 906-912
14. Prien R.F., Caffey Jr. E.M., and Klett C.J. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch. Gen. Psychiatry 26 (1972) 146-153
15. Sachs G.S., and Gardner-Schuster E.E. Adjunctive treatment of acute mania: a clinical overview. Acta Psychiatr. Scand. Suppl. 116 (2007) 27-34
16. Sachs G., Chengappa K.N., Suppes T., Mullen J.A., Brecher M., Devine N.A., et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar. Disord. 6 (2004) 213-223
17. Tohen M., Greil W., Calabrese J.R., Sachs G.S., Yatham L.N., Oerlinghausen B.M., et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am. J. Psychiatry 162 (2005) 1281-1290
18. Valenstein M., McCarthy J.F., Austin K.L., Greden J.F., Young E.A., and Blow F.C. What happened to lithium? Antidepressant augmentation in clinical settings. Am. J. Psychiatry 163 (2006) 1219-1225